Coccidioidomycosis and Tumor Necrosis Factor-α Inhibitor Drugs
Screening of asymptomatic coccidioidomycosis within a Coccidioides-endemic area allowed for identifying and managing asymptomatic cases before patients began tumor necrosis factor-α inhibitor therapy. Source: Coccidioidomycosis Screening Benefits TNFi Therapy Recipients – Infectious Disease Advisor TNFi therapies have advanced the treatment of numerous inflammatory diseases because they act by impairing select functions of cellular immunity. However,…